is the CEO of Actarmo Medical GmbH. Actarmo Medical is a CRO for GMP testing and development of inhalation products in the pharmaceutical sector. In addition, Actarmo Medical GmbH also offers consulting services r the Medical Device Regulation (MDR) and on inhalation products. In addition to CMC and regulatory activities, this also includes the transfer of customer projects to contract manufacturers.
Before his current position, Thomas Weuthen held various roles at Sandoz AG, where he was responsible for the development of dry powder inhalers and asthma sprays for the European and American markets. These activities included pharmaceutical development, clinical studies and the marketing authorisation of products. Mr. Weuthen was also responsible for the global portfolio of respiratory products at Sandoz.